Growth Metrics

Bioadaptives (BDPT) Change in Accured Expenses (2018 - 2025)

Bioadaptives' Change in Accured Expenses history spans 7 years, with the latest figure at $1957.0 for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 79.49% to $1957.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $53267.0, a 18.82% increase, with the full-year FY2025 number at $53267.0, up 18.82% from a year prior.
  • Change in Accured Expenses hit $1957.0 in Q4 2025 for Bioadaptives, down from $26687.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for BDPT hit a ceiling of $109110.0 in Q3 2021 and a floor of -$16261.0 in Q3 2023.
  • Historically, Change in Accured Expenses has averaged $26764.1 across 5 years, with a median of $12265.0 in 2025.
  • Biggest five-year swings in Change in Accured Expenses: surged 11289.35% in 2021 and later plummeted 210.27% in 2023.
  • Tracing BDPT's Change in Accured Expenses over 5 years: stood at $107924.0 in 2021, then crashed by 89.27% to $11575.0 in 2022, then tumbled by 240.48% to -$16261.0 in 2023, then skyrocketed by 158.68% to $9542.0 in 2024, then tumbled by 79.49% to $1957.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for BDPT at $1957.0 in Q4 2025, $26687.0 in Q3 2025, and $12265.0 in Q2 2025.